- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 18.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 11.87M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 126.92K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.82M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $7M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.76M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.56M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.76M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $5.71M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $12.33M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.56M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.49M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.56M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $12.32M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $9.49M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.32M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.49M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$70.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$70.49 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $61K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $6.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.62M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$8.95M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.8M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$10.67M |